The Screening and Early Detection Portfolio at the Canadian Partnership Against Cancer works with partners across the country to increase the number of individuals getting screened appropriately and promote high quality cancer screening services.
National Colorectal Cancer Screening Network
The Partnership convenes the National Colorectal Cancer Screening Network which has been in place since 2007. The Network brings together key stakeholders from across the country to promote active engagement and serves as a national platform for knowledge exchange. This helps engage the colorectal cancer screening community, improve the patient experience across the cancer journey, leverage expertise, and make evidence-based recommendations to the cancer control system. The Network’s primary aim is to improve participation and enhance quality in colorectal cancer screening in Canada.
Monitoring and Evaluation Working Group
The Monitoring and Evaluation Working Group, a subset of the Network, enables regular reporting and analysis of quality indicators. This group leads the development of biennial results reports for measuring quality indicators for colorectal cancer screening programs across Canada.
Lastly, the Screening and Early Detection Portfolio embarks on quality improvement opportunities which often take the form of expert workshops or special reports.
Reports and resources
See below for a variety of resources related to colorectal cancer screening.
|Colorectal cancer screening – environmental scan
See the key components for colorectal cancer screening programs and strategies across Canada. Released: January 2015
|Cancer Screening in Canada: An overview of screening participation for breast, cervical and colorectal cancer
This pan-Canadian report compares programmatic participation and self-reported utilization (both programmatic and non-programmatic screening) for breast, cervical and colorectal cancer within and outside of current national screening guidelines. This approach supports the Partnership’s goal of increasing screening within guidelines while decreasing screening outside of guidelines. Released: January 2015
|Colorectal Cancer Screening in Canada: Monitoring & Evaluation of Quality Indicators – Results Report, January 2011 – December 2012
This report presents the colorectal cancer screening program quality markers for Canada in 2011 and 2012. It builds on the 2009–2010 first-round screening report for colorectal cancer. The evaluation framework includes 12 quality markers that were measured in the previous report, as well as three additional markes (retention rate, 14-day unplanned hospitalization after follow-up colonoscopy, and interval colorectal cancer rate). Released: December 2014
|Colorectal Cancer Screening in Canada: Program Performance Results Report, January 2009 – December 2011
This colorectal cancer screening report gives early results for key markers and targets for the provinces that were able to provide first-round data from January 1, 2009 to December 31, 2011. Released: December 2013
|Quality Determinants and Indicators for Measuring Colorectal Cancer Screening Program Performance in Canada – May 2013
This document supports the implementing of population-based colorectal cancer (CRC) screening in Canada. It also outlines specific quality determinants and indicators for CRC screening programs in Canada. Quality determinants are concepts, processes and activities that contribute to the quality of the program. Released: May 2013
A patient-friendly colorectal cancer site that encourages people to get checked for colon cancer, spread the word and have a “colonversation.”
The partnership responds to new screening-trial research through the Anticipatory Science Initiative. When a new research paper is published, a cross-Canada approach is taken to create a stream-lined, timely synopsis and inform partners about key information on specific screening tests.
The Canadian Task Force on Preventive Health Care (CTFPHC), established by the Public Health Agency of Canada, publishes national clinical practice guideline recommendations for colorectal cancer screening.